|
1
|
Li CI, Malone KE and Daling JR:
Differences in breast cancer stage, treatment, and survival by race
and ethnicity. Arch Intern Med. 163:49–56. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gao F, Wang J, Liu X, et al: Racial
differences in breast cancer survival in Yunnan. Zhong guo yi xue
li lun yu shi jian za zi. 1:778–779. 2003.(In Chinese).
|
|
3
|
Newman B, Moorman PG, Millikan R, et al:
The Carolina Breast Cancer Study: intergrating population-based
epidemiology and molecular biology. Breast Cancer Res Treat.
35:51–60. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hammond ME, Hayes DF, Wolff AC, et al:
American society of clinical oncology/college of american
pathologists guideline recommendations for immunohistochemical
testing of estrogen and progesterone receptors in breast cancer. J
Oncol Pract. 6:195–197. 2010. View Article : Google Scholar
|
|
5
|
Breast cancer compiling group. Guidelines
for HER2 detection in breast cancer, the 2009 version. Chinese
Journal of Pathology. 38:836–840. 2009.(In Chinese).
|
|
6
|
Kuiper GG, Enmark E, Pelto-Huikko M, et
al: Cloning of a novel receptor expressed in rat prostate and
ovary. Proc Natl Acad Sci USA. 93:5925–5930. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dotzlaw H, Leygue E, Watson PH and Murphy
LC: Expression of estrogen receptor-beta in human tumors. J Clin
Endocrinol Metab. 82:2371–2374. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Järvinen TA, Pelto-Huikko M, Holli K and
Isola J: Estrogen receptor beta is coexpressed with ERalpha and PR
and associated with nodal status, grade, and proliferation rate in
breast cancer. Am J Pathol. 156:29–35. 2000.PubMed/NCBI
|
|
9
|
Mann S, Laucirica R, Carlson N, et al:
Estrogen receptor beta expression in invasive breast cancer. Hum
Pathol. 32:113–118. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fuqua SA, Schiff R, Parra I, et al:
Estrogen receptor beta protein in human breast cancer: correlation
with clinical tumor parameters. Cancer Res. 63:2434–2439. 2003.
|
|
11
|
Han J, Wang PJ, Tang RY, et al: The
expression of estrogen receptor α, β in different breast tissues
and its relation with breast cancer. Tongji xue bao. 26:21–24.
2005.(In Chinese).
|
|
12
|
Li Y, Wu MB, Zhao XX, et al: Loss of
heterozygosity and cloning of human chromosome 3p24 in esophageal
carcinoma. Xinjiang Yi Ke Da Xue Xue Bao. 26:224–226. 2003.(In
Chinese).
|
|
13
|
Chen R, Li TF, Wang XL, et al: Clinical
epidemiological analysis of cervical carcinoma of 2417 cases in
Xinjiang. Zhonghua Zhong Liu Fang Zhi Za Zhi. 15:329–331. 2008.(In
Chinese).
|
|
14
|
Elledge RM, Clark GM, Chamness GC and
Osborne CK: Tumor biologic factors and breast cancer prognosis
among white, Hispanic, and black women in the United State. J Natl
Cancer Inst. 86:705–712. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miller BA, Hankey BF and Thomas TL: Impact
of sociodemographic factors, hormone receptor status, and tumor
grade on ethnic differences in tumor stage and size for breast
cancer in US women. Am J Epidemiol. 155:534–545. 2002. View Article : Google Scholar
|
|
16
|
Schwartz LH, Koerner FC, Edgerton SM, et
al: pS2 expression and response to hormonal therapy in patients
with advanced breast cancer. Cancer Res. 51:624–628.
1991.PubMed/NCBI
|
|
17
|
Al-Abbadi MA, Washington TA, Saleh HA, et
al: Differential expression of HER-2/NEU receptor of invasive
mammary carcinoma between Caucasian and African American patients
in the Detroit metropolitan area. Correlation with overall survival
and other prognostic factors. Breast Cancer Res Treat. 97:3–8.
2006. View Article : Google Scholar
|
|
18
|
Yang H, Shi X, Lv X and Li H: The
difference in expressions of CD44v5 and HER4 between Uygur and Han
with breast invasive duct carcinoma. Zhongguo Lao Nian Xue Za Zhi.
26:589–590. 2006.(In Chinese).
|
|
19
|
Perou CM, Sørlie T, Eisen MB, et al:
Molecular portraits of human breast tumours. Nature. 406:747–752.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Carey LA, Perou CM, Livasy CA, et al:
Race, breast cancer subtypes, and survival in the Carolina Breast
Cancer Study. JAMA. 295:2492–2502. 2006. View Article : Google Scholar : PubMed/NCBI
|
